Ablation Frontiers Announces CE Mark and Commercial Launch of Novel Cardiac Ablation System



    Regulatory Approval Clears Path Towards European Commercialization

    CARLSBAD, Calif., June 7 /CNW/ -- Ablation Frontiers, Inc., developer and
manufacturer of three-dimensional catheters for the treatment of atrial
fibrillation (AF) announced today that in December 2006, it received the CE
Mark for its Cardiac Ablation System consisting of a portfolio of anatomical
based catheters and a uniquely designed radiofrequency (RF) energy delivery
system. Receipt of the CE Mark certification allowed the company to initiate
the first commercial use of its Ablation System on January 18, 2007. The
company has initiated a commercial launch of its products with key
international cardiac centers throughout the European Union and other
International markets that recognize the CE Mark.
    Ablation Frontiers proprietary products are designed to treat all types
of atrial fibrillation, including patients with paroxysmal, persistent and the
more difficult to treat, permanent AF. The novel catheters effectively treat
tissue in the right and/or left atrium through percutaneous access to the
heart. Ablation Frontiers, Inc. has developed a tool kit of catheters
specifically designed for the atrial anatomy and AF ablation. The catheters
are powered by a cleverly designed RF energy source that allows a physician to
precisely control the energy and tailor treatment for the individual needs of
the patient. Design goals centered on the need to develop a very simple but
elegant therapy solution that could greatly reduce procedure times, improve
safety and be easily learned by most electrophysiologists. Unlike all other
treatment approaches, this technology does not rely on expensive
three-dimensional mapping or complex catheter steering robotics. The Company's
percutaneous cardiac catheters are inserted through a patient's leg vein and
advanced into the right and/or left atrium. Each catheter is designed to map,
and using radiofrequency energy, ablate specific target sites through
simultaneous selective combinations of multiple electrode channels.
    The unique catheter designs result in increased accuracy for the
physician due to the stabilizing nature of the three-dimensional catheters and
the multi-array of electrodes on each catheter. The Ablation Frontiers Cardiac
Ablation System allows physicians to tailor the ablation therapy to suit the
needs of each patient in as much as half the time as a conventional point to
point catheter ablation procedure. Traditional AF ablation procedures
currently take up to 4 hours or longer to perform.
    "It is truly exciting to be at the forefront of a new technology that can
greatly simplify the treatment of atrial fibrillation and result in more
patients receiving advanced treatment," stated Keegan Harper, CEO, for
Ablation Frontiers.
    "This is clearly a therapy designed by electrophysiologists for
electrophysiologists. I have been using these catheters on patients with all
types of atrial fibrillation, from paroxysmal to the most challenging of
longstanding persistent AF. I have achieved excellent early results and
outcomes as well as substantially reduced my procedure times", stated Dr
Stephen Furniss, Consultant Cardiologist & Hon Senior Lecturer, Freeman
Hospital, Newcastle upon Tyne, UK.
    "We are very pleased with the results of our European clinical trials,
and given the significant customer interest and high level of early adoption,
we are looking forward to a more comprehensive launch of our technology into
the European and key international markets" stated Martin Chambers, Vice
President, Global Sales & Marketing, for Ablation Frontiers.
    Ablation procedures are used to treat cardiac arrhythmias, such as atrial
fibrillation. AF is an uncontrollable, rapid heartbeat that can lead to
serious complications such as strokes or heart failure. Globally, in excess of
10 million people are afflicted with AF. During the ablation procedure, a
catheter is inserted into a specific area of the heart. Energy is directed
through the catheter to small areas of the heart muscle that permit the
abnormal heart rhythm. This energy "disconnects" the pathway of the abnormal
rhythm.
    The Cardiac Ablation Technology System provides a catheter-based solution
to AF that is appropriate for most hospital facilities when performed by a
cardiac electrophysiologist.

    Ablation Frontiers is a privately held company that was founded in 2004.
You can learn more about the company at http://www.ablationfrontiers.com





For further information:

For further information: Keegan Harper, President and CEO of Ablation
Frontiers, Inc., +1-760-438-4868, ext. 117; Web Site:
http://www.ablationfrontiers.com

Organization Profile

ABLATION FRONTIERS, INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890